Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LFST Stock Forecast 2026-2027
$7.34
Current Price
$2.80B
Market Cap
Buy 9
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to LFST Price Targets
+77.1%
To High Target of $13.00
+46.5%
To Median Target of $10.75
+22.6%
To Low Target of $9.00
LFST Price Momentum
-5.4%
1 Week Change
-4.7%
1 Month Change
+24.8%
1 Year Change
+4.3%
Year-to-Date Change
-17.4%
From 52W High of $8.89
+96.3%
From 52W Low of $3.74
📊 TOP ANALYST CALLS
Did LFST Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if LifeStance is one of their latest high-conviction picks.
Latest LFST Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, LFST has a bullish consensus with a median price target of $10.75 (ranging from $9.00 to $13.00). The overall analyst rating is Strong Buy (8.9/10). Currently trading at $7.34, the median forecast implies a 46.5% upside. This outlook is supported by 9 Buy, 2 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Scott Fidel at Goldman Sachs, suggesting a 22.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LFST Analyst Ratings
9
Buy
2
Hold
0
Sell
LFST Price Target Range
Low
$9.00
Average
$10.75
High
$13.00
Current: $7.34
Latest LFST Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LFST.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 5, 2026 | Goldman Sachs | Scott Fidel | Neutral | Initiates | $9.00 |
| May 14, 2026 | JP Morgan | Neutral | Maintains | $N/A | |
| May 8, 2026 | BTIG | Buy | Maintains | $N/A | |
| Mar 6, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Feb 26, 2026 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Feb 26, 2026 | UBS | Buy | Maintains | $N/A | |
| Feb 26, 2026 | Keybanc | Overweight | Maintains | $N/A | |
| Feb 2, 2026 | BTIG | Buy | Maintains | $N/A | |
| Dec 12, 2025 | BTIG | Buy | Maintains | $N/A | |
| Dec 9, 2025 | Barclays | Overweight | Initiates | $N/A | |
| Nov 13, 2025 | BMO Capital | Outperform | Initiates | $N/A | |
| Nov 7, 2025 | UBS | Buy | Maintains | $N/A | |
| Nov 6, 2025 | BTIG | Buy | Maintains | $N/A | |
| Aug 8, 2025 | UBS | Buy | Maintains | $N/A | |
| May 27, 2025 | UBS | Buy | Upgrade | $N/A | |
| Apr 8, 2025 | Keybanc | Overweight | Initiates | $N/A | |
| Apr 3, 2025 | Canaccord Genuity | Buy | Initiates | $N/A | |
| Dec 16, 2024 | Goldman Sachs | Buy | Upgrade | $N/A | |
| Nov 11, 2024 | Barclays | Underweight | Maintains | $N/A | |
| Aug 15, 2024 | UBS | Neutral | Maintains | $N/A |
LifeStance Health Group, Inc. (LFST) Competitors
The following stocks are similar to LifeStance based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
LifeStance Health Group, Inc. (LFST) Financial Data
LifeStance Health Group, Inc. has a market capitalization of $2.80B with a P/E ratio of 123.5x. The company generates $1.49B in trailing twelve-month revenue with a 1.6% profit margin.
Revenue growth is +21.2% quarter-over-quarter, while maintaining an operating margin of +5.5% and return on equity of +1.6%.
Valuation Metrics
Market Cap
$2.80B
Enterprise Value
$3.16B
P/E Ratio
123.5x
PEG Ratio
0.0x
Price/Sales
1.9x
Growth & Margins
Revenue Growth (YoY)
+21.2%
Gross Margin
+33.7%
Operating Margin
+5.5%
Net Margin
+1.6%
EPS Growth
+1,908.9%
Financial Health
Cash/Price Ratio
+6.8%
Current Ratio
1.5x
Debt/Equity
32.3x
ROE
+1.6%
ROA
+1.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
LifeStance Health Group, Inc. (LFST) Business Model
About LifeStance Health Group, Inc.
What They Do
Provides comprehensive behavioral health services.
Business Model
The company operates by offering a range of mental health services, including psychiatrist and therapist consultations, both in-person and via telehealth. It generates revenue through patient visits, collaborating with insurance providers to facilitate access to care, thereby ensuring a steady income stream while enhancing patient accessibility.
Additional Information
Lifestance Health is positioned to address the increasing demand for mental health services in the U.S., playing a pivotal role in shaping mental health policies and practices. Its extensive network of clinicians and commitment to patient-centered care further solidify its significance in the growing behavioral health market.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
8,349
CEO
Mr. David Patrick Bourdon
Country
United States
IPO Year
2021
Website
lifestance.comLifeStance Health Group, Inc. (LFST) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 37.3% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
May 29, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
10 days ago
Quick Summary
Wall Street analysts' average price targets suggest a 37.3% upside for LifeStance Health (LFST), supported by positive earnings estimate revisions.
Why It Matters
Wall Street analysts see a 37.3% upside for LifeStance Health (LFST), suggesting potential growth. Positive earnings revisions could further boost investor sentiment and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
LifeStance Health (LFST) has formed a hammer chart pattern, suggesting support, alongside rising earnings estimate revisions, potentially indicating a trend reversal.
Why It Matters
The hammer chart pattern suggests potential price support for LifeStance Health, while rising earnings estimates indicate a possible trend reversal, signaling a buy opportunity.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
LifeStance Health Group (LFST) shares are rising, with expectations of continued growth due to favorable earnings estimate revisions.
Why It Matters
Rising earnings estimate revisions for LifeStance Health Group suggest improved financial performance, potentially driving share price appreciation and attracting investor interest.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
LifeStance Health Group, Inc. (LFST) presented at the Bank of America Global Healthcare Conference, discussing key insights and future strategies.
Why It Matters
LifeStance Health's presentation at a major healthcare conference signals its strategic direction and growth potential, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
26 days ago
Quick Summary
LifeStance Health (LFST) has a consensus price target indicating a potential 31% upside. Recent earnings estimate revisions may suggest short-term growth for the stock.
Why It Matters
The 31% upside potential suggests strong growth expectations for LifeStance Health (LFST), while rising earnings estimates indicate possible short-term gains, signaling a bullish outlook.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
LifeStance Health Group (LFST) is being evaluated for its potential as a strong stock choice for momentum investors.
Why It Matters
LifeStance Health Group's potential as a top stock pick signals strong momentum, indicating possible price appreciation and attracting interest from growth-focused investors.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About LFST Stock
What is LifeStance Health Group, Inc.'s (LFST) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, LifeStance Health Group, Inc. (LFST) has a median price target of $10.75. The highest price target is $13.00 and the lowest is $9.00.
Is LFST stock a good investment in 2026?
According to current analyst ratings, LFST has 9 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.34. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LFST stock?
Wall Street analysts predict LFST stock could reach $10.75 in the next 12 months. This represents a 46.5% increase from the current price of $7.34. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is LifeStance Health Group, Inc.'s business model?
The company operates by offering a range of mental health services, including psychiatrist and therapist consultations, both in-person and via telehealth. It generates revenue through patient visits, collaborating with insurance providers to facilitate access to care, thereby ensuring a steady income stream while enhancing patient accessibility.
What is the highest forecasted price for LFST LifeStance Health Group, Inc.?
The highest price target for LFST is $13.00 from at , which represents a 77.1% increase from the current price of $7.34.
What is the lowest forecasted price for LFST LifeStance Health Group, Inc.?
The lowest price target for LFST is $9.00 from Scott Fidel at Goldman Sachs, which represents a 22.6% increase from the current price of $7.34.
What is the overall LFST consensus from analysts for LifeStance Health Group, Inc.?
The overall analyst consensus for LFST is bullish. Out of 3 Wall Street analysts, 9 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $10.75.
How accurate are LFST stock price projections?
Stock price projections, including those for LifeStance Health Group, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 9, 2026 3:10 AM UTC